Papers - KATO, Masashi
-
Molecular network associated with MITF on skin melanoma development and progression.
Yajima I, Kumasaka YM, Thang ND, Goto Y, Takeda K, Iida M, Ohgami N, Tamura H, Yamanoshita O, Kawamoto Y, Furukawa K, Kato M
J Skin Cancer Vol. 2011 page： 730170 2011
-
c-Ret-mediated hearing loss in mice with Hirschsprung disease.
Ohgami N, Ida M, Shimotake T, Sakashita N, Sone M, Nakashima T, Tabuchi K,
Proc Natl Acad Sci USA Vol. 107 ( 29 ) page： 13051-6 2010.7
-
Targeting Surface Nucleolin with a Multivalent Pseudopeptide Delays Development of Spontaneous Melanoma in RET Transgenic Mice.
Khoury DE, Destouches D, Lengagne R, Krust B, Hamma-Kourbali Y, Garcette M, Niro S, Kato M, Briand J-P, Courty J, Hovanessian AG, Prévost-Blondel A
BMC Cancer Vol. 10 page： 325 2010.6
-
c-Ret-mediated hearing loss in mice with Hirschsprung disease. Reviewed
Ohgami N, Ida M, Shimotake T, Sakashita N, Sone M, Nakashima T, Tabuchi K, Hoshino T, Shimada A, Tsuzuki T, Yamamoto M, Sobue G, Jijiwa M, Asai N, Hara A, Takahashi M, Kato M.
Proc Natl Acad Sci USA Vol. 107 ( 29 ) page： 13051-6 2010.6
-
Tumor cells disseminate early but immunosurveillance limits metastatic outgrowth in a mouse model of melanoma.
Eyles J, Puaux A, Wang J, Toh B, Prakash C, Hong M, Zheng L, Ong LC, Jin Y, Kato M, Blondel AP, Chow P, Yang H, Abastado J-P
J Clin Invest Vol. 120 ( 6 ) page： 2030-9 2010.6
-
A redox-linked novel pathway for arsenic-mediated RET tyrosine kinase activation
Kato M, Takeda K, Hossain K, Thang D. Nguyen, Kaneko Y, Kumasaka M, Yamanoshita O, Uemura N, Takahashi M, Ohgami N, Kawamoto Y
J Cell Biochem Vol. 110 page： 399-407 2010.5
-
c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell lines Open Access
Ohshima Y, Yajima I, Takeda K, Iida M, Kumasaka M, Matsumoto Y, Kato M
PLoS ONE Vol. 5 ( 4 ) page： e10279 2010.4
-
Ergün S and Schadendorf D: Resistance to anti-angiogenic therapy is directed by vascular phenotype, vessel stabilization and maturation in malignant melanoma.
Helfrich I, Scheffrahn I, Bartling S, Weis J, von Felbert V, Middleton M, Kato M
J Exp Med Vol. 207 ( 3 ) page： 491-503 2010.3
-
Increased CD109 expression levels in human malignant melanoma
Ohshima Y, Yajima I, Kumasaka YM, Yanagishita T, Watanabe D, Takahashi M, Inoue Y, Ihn H, Matsumoto Y, Kato M
J Dermatol Sci Vol. 57 ( 2 ) page： 140-2 2010.2
-
A Novel Mouse Model for de novo melanoma
Kumasaka YM, Yajima I, Hossain K, Iida M, Tsuzuki T, Ohno T, Takahashi M, Yanagisawa M, Kato M
Cancer Res Vol. 70 ( 1 ) page： 24-9 2010.1
-
Toxic Elements in Well Water from Malaysia
Kato M, Ohnuma S, Kato Y, Thang D. Nguyen, Yajima I, Hoque Z. Mohammad, Shekhar U. Hossain
Toxicol Environ Chem Vol. 92 ( 9 ) page： 1609-12 2010
-
1,4-butanediyl-bismethanethiosulfonate (BMTS) induces reactive oxygen species-mediated apoptotic signals independent of stress-activated MAPK cascade in Jurkat cells.
Hossain K, Kawamoto Y, Hamada M, Akhand A, Yanagishita T, Hoque Md. A, Tsuboi H, Kato M, Nakashima I
J Cell Biochem Vol. 108 ( 5 ) page： 1059-65 2009.12
-
Skin Melanoma Development in Ret Transgenic Mice Despite the Depletion of CD25+FoxP3+ Regulatory T-Cells in Lymphoid Organs.
Kimpfler S, Ring S, Falk C, Osen W, Kato M, Mahnke K, Schadendorf D, Umansky V
J Immunol Vol. 183 ( 10 ) page： 6330-7 2009.11
-
Mendelsohn C, Costantini F: Ret-dependent cell rearrangements in the Wolffian duct epithelium initiate ureteric bud morphogenesis.
Chi X, Michos O, Shakya R, Riccio P, Enomoto H, Licht JD, Asai N, Takahashi M, Ohgami N, Kato M
Dev Cell Vol. 17 ( 2 ) page： 199-209 2009.8
-
Activation of p38 MAPK Drives Dendritic Cells to Become Tolerogenic in Ret Transgenic Mice Spontaneously Developing Melanoma.
Zhao F, Falk C, Osen W, Kato M, Schadendorf D, Umansky V
Clin Cancer Res Vol. 15 ( 13 ) page： 4382-90 2009.7
-
Zinc finger protein 28 as a novel melanoma-related molecule.
Yajima I, Kumasaka M, Thang ND, Yanagishita T, Ohgami N, Kallenberg D, Naito Y, Yoshikawa T, Sakashita N, Kato M.
J Dermatol Sci Vol. 55 ( 1 ) page： 68-70 2009.7
-
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, a Ruggeri L, Capanni M, Umansky V, Paschen A, Sucker A, Pende D, Groh V, Biassoni R, Höglund P, Kato M, Shibuya K, Schadendorf D, Anichini A, Ferrone S, Velardi A, Kärre K, Shibuya A, Carbone E, Colucci F.
J Clin Invest Vol. 119 ( 5 ) page： 1251-63 2009.5
-
Melanoma Specific Memory T Cells Are Functionally Active in Ret Transgenic Mice Without Macroscopical Tumors.
Umansky V, Abschuetz O, Osen W, Ramacher M, Zhao F, Kato M
Cancer Res Vol. 68 ( 22 ) page： 9451-8 2008.11
-
BMP-4 Upregulates Kit Expression in Mouse Melanoblasts prior to the Kit-Dependent Cycle of Melanogenesis.
Kawakami T, Kimura S, Kawa Y, Kato M, Mizoguchi M, Soma Y
J Invest Dermatol Vol. 128 ( 5 ) page： 1220-6 2008.5
-
Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases.
Lengagne R, Graff-Dubois S, Garcette M, Renia L, Kato M, Guillet J, Engelhard HV, Avril M, Abastado J and Prévost-Blondel A
J Immunol Vol. 180 ( 1 ) page： 130-7 2008.1